• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PERM); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PERM); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PXT231218
Medical Device Problem Codes Component Incompatible (1108); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 05/12/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Please note that this event was also reported in medwatch(es) #3007284313-2020-00012 and.Details of the event required a separate medwatch submission for the component identified in field(s); as such this medwatch is being submitted.
 
Event or Problem Description
On (b)(6) 2012, this patient underwent endovascular treatment of an abdominal aortic aneurysm measuring approximately 45mm in diameter, and was implanted with gore® excluder® aaa endoprosthesis.In the beginning of (b)(6) 2020, follow-up imaging revealed aneurysm enlargement to approximately 60 mm in diameter and a type ii endoleak from the l4 lumbar artery.Additionally, a proximal type i endoleak was determined along with a type iii endoleak due to component disconnect of the contralateral leg component from the contralateral gate.On (b)(6) 2020, a reintervention was performed and an endurant cuff was placed to treat the proximal type i endoleak, and a contralateral leg component was placed to treat and reline the type iii endoleak.No treatment for the type ii endoleak was performed but future treatment is planned.The type i endoleak was reported to have not been resolved by placement of the endurant cuff.The patient tolerated the procedure.
 
Additional Manufacturer Narrative
G9: please note that this event was also reported in medwatch(es) #3007284313-2020-00012 and 2017233-2020-00392.Details of the event required a separate medwatch submission for the component identified in field(s) d4 above; as such this medwatch is being submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PERM)
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key10098773
Report Number2953161-2020-00013
Device Sequence Number3448734
Product Code MIH
UDI-Device Identifier00733132610129
UDI-Public00733132610129
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2012
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/30/2014
Device Model NumberPXT231218
Device Catalogue NumberPXT231218
Device Lot Number9840571
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date05/28/2020
Supplement Report FDA Received Date06/10/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Other;
Patient Age82 YR
-
-